Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy

Endometrial cancer as an attractive target for checkpoint inhibitor-based therapy

Date

22 Sep 2020

Session

GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy

Presenters

Robert Coleman

Authors

R.L. Coleman

Author affiliations

  • Us Oncology Research Gynecologic Oncology Dept, US Oncology Research, 77380 - The Woodlands/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and Introduction

Presenter: Robert Coleman

Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy

Resources:

Webcast

Conclusion

Presenter: Robert Coleman

Session: GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.